18-62143306-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_176787.5(PIGN):c.963G>A(p.Gln321Gln) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.0000161 in 1,493,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_176787.5 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGN | NM_176787.5 | c.963G>A | p.Gln321Gln | splice_region_variant, synonymous_variant | Exon 11 of 31 | ENST00000640252.2 | NP_789744.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGN | ENST00000640252.2 | c.963G>A | p.Gln321Gln | splice_region_variant, synonymous_variant | Exon 11 of 31 | 1 | NM_176787.5 | ENSP00000492233.1 | ||
PIGN | ENST00000400334.7 | c.963G>A | p.Gln321Gln | splice_region_variant, synonymous_variant | Exon 10 of 30 | 1 | ENSP00000383188.2 | |||
PIGN | ENST00000638424.1 | n.963G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 9 of 29 | 5 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152036Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000831 AC: 16AN: 192646Hom.: 0 AF XY: 0.0000782 AC XY: 8AN XY: 102322
GnomAD4 exome AF: 0.0000149 AC: 20AN: 1341494Hom.: 0 Cov.: 21 AF XY: 0.00000749 AC XY: 5AN XY: 667804
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74386
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Pathogenic:6
Variant summary: PIGN c.963G>A (p.Gln321Gln), affecting the last nucleotide of exon 11, results in a synonymous change but alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Two predict the variant abolishes a canonical 5' splicing donor site and one predicts the variant weakens the 5' donor site. At least one publication reports experimental evidence that this variant indeed affects mRNA splicing, producing two different aberrant transcripts, both of which result in a premature stop codon and are expected to undergo nonsense mediated decay (e.g. Ohba_2014). The variant allele was found at a frequency of 8.3e-05 in 192646 control chromosomes (gnomAD). c.963G>A has been reported in the literature as a biallelic genotype in multiple individuals affected with Multiple Congenital Anomalies-Hypotonia Syndrome 1 (e.g. Ohba_2014, Xiao_2020, Wang_2021). These data indicate that the variant is likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 24253414, 33502061, 33193741). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
ACMG classification criteria: PS3 supporting, PM2 supporting, PM3 very strong, PP1 supporting -
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.008%). Predicted Consequence/Location: Synonymous variant In silico tools predict the variant to alter splicing and produce an abnormal transcript (SpliceAI: 0.69). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID: 24253414). The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000101048 /PMID: 24253414, 32712949). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
This sequence change affects codon 321 of the PIGN mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PIGN protein. This variant also falls at the last nucleotide of exon 11, which is part of the consensus splice site for this exon. This variant is present in population databases (rs587777187, gnomAD 0.1%). This variant has been observed in individual(s) with PIGN-congenital disorder of glycosylation (PMID: 24253414, 33193741). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 101048). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate that Q321= leads to aberrant splicing, resulting in two different frameshift variants, p.Ala322Valfs*24 and p.Glu308Glyfs*2, respectively (Ohba et al., 2014); Alters the last nucleotide of the exon and is predicted to destroy the splice donor site and result in aberrant splicing, although in the absence of functional evidence, the actual effect of this sequence change is unknown; This variant is associated with the following publications: (PMID: 32860008, 28273706, 24253414, 32036363, 32220244, 33193741, 33502061, 32712949) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at